SCHEMBL4096973

SCHEMBL4096973

COc1ccc(C(=O)c2ccc(OCCc3nc(-c4ccccc4)oc3C)nc2)c(O[C@H](C)C(=O)O)c1

nearest known ligand 0.59

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 20/20 0.59
PPARA Q07869 18/20 0.59
PPARD Q03181 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4092567 0.93 PPARG (0.57) PPARGPPARA
SCHEMBL4103337 0.93 PPARG (0.57) PPARGPPARA
SCHEMBL4092245 0.91 PPARG (0.69) PPARGPPARAPPARD
SCHEMBL4104255 0.88 PPARG (0.55) PPARGPPARA
SCHEMBL4101949 0.86 PPARG (0.57) PPARGPPARA
SCHEMBL4099878 0.86 PPARG (0.66) PPARGPPARAPPARD
SCHEMBL4099663 0.86 PPARG (0.66) PPARGPPARAPPARD
SCHEMBL4093286 0.86 PPARG (0.66) PPARGPPARAPPARD
SCHEMBL4096642 0.82 MAPT (0.53) PPARGPPARA
SCHEMBL4097707 0.82 PPARG (0.60) PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054435-A1 Phenoxyalkanoic Acid Compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-02-26 US disclosed
EP-1911738-A1 PHENOXYALKANOIC ACID COMPOUND Takeda Pharmaceutical Company Limited (JP) 2008-04-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054435-A1 Phenoxyalkanoic Acid Compound PNLIP, GPR119, LIPC PPARG 23/4885PPARA 8/4885PPARD 30/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.